Loading clinical trials...
Loading clinical trials...
This study aims to evaluate the impact of the triglyceride-glucose (TyG) index on the angiographic profiling of non-diabetic patients with premature coronary artery disease (CAD).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sohag University
NCT06933355 · Kidney Transplantation Recipients, Magnetic Resonance Imaging (MRI), and more
NCT07190144 · The Study Focused on the Vascular Effects of Semaglutide in Both Diabetic and Non-diabetic Patients, Obesity &Amp; Overweight
NCT03036592 · Non-Diabetic Disorder of Endocrine Pancreas
NCT01132326 · Primary Autonomic Failure, Dopamine Beta Hydroxylase Deficiency, and more
NCT04452396 · Hypoglycemia, Reactive, Hypoglycaemia Night, and more
Sohag University
Sohag
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions